-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Twist Bioscience, Raises Price Target to $120

Benzinga·07/14/2026 11:58:26
Listen to the news
Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $90 to $120.